| Tested compounds/extract |
IC50 (Mean ± S.E.) |
| HCT116 |
HEP2 |
MCF7 |
HELA |
HEPG2 |
| MEP |
4.36 ± 0.32 |
4.99 ± 0.36 |
6.56 ± 0.32 |
4.90 ± 0.21 |
2.14 ± 0.35 |
| S1 |
2.97 ± 0.38 |
3.43 ± 0.49 |
2.97 ± 0.29 |
3.43 ± 0.50 |
2.51 ± 0.21 |
| S2 |
2.23 ± 0.35 |
12 ± 0.79 |
2.36 ± 0.41 |
13.4 ± 1.55 |
2.12 ± 0.90 |
| S3 |
5.20 ± 0.70 |
11.2 ± 0.69 |
4.51 ± 0.21 |
10.01 ± 0.21 |
3.52 ± 0.21 |
| S4 |
2.97 ± 0.57 |
3.13 ± 0.26 |
3.13 ± 0.11 |
2.97 ± 0.22 |
2.67 ± 0.44 |
| S5 |
6.79 ± 1.41 |
6.94 ± 0.27 |
8.46 ± 0.45 |
9.07 ± 0.41 |
4.34 ± 0.31 |
| Doxorubicin® |
0.69 ± 0.21 |
1.10 ± 0.30 |
0.7 ± 0.12 |
0.91 ± 0.10 |
0.67 ± 0.21 |
MEP: Methanol Extract of S. melongena peels; HCT116: Colon cancer cell line; HEP2: Lung cancer cell line; MCF7: Breast cancer cell line; HELA: Cervix cancer cell
line; HEPG2: Liver cancer cell line; SD: Standard error for n = 3 |
